Skip to main content

Part of OCAFP - Geographic variation

Ovarian Cancer Audit Feasibility Pilot Steering Group

First chapter of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England.

Current Chapter

Current chapter – Ovarian Cancer Audit Feasibility Pilot Steering Group


Summary

First chapter of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England.


Steering Group members

Chair

Mr Andy Nordin, Consultant Gynaecological Oncologist, East Kent Hospitals, Clinical Advisor, National Cancer Registration and Analysis Service (NCRAS)

Target Ovarian Cancer

Annwen Jones OBE, Chief Executive

Rebecca Rennison, Director of Public Affairs and Services

British Gynaecological Cancer Society (BGCS)

Professor Sudha Sundar, President and Consultant Gynaecological Oncologist, Pan Birmingham Gynaecological Cancer Centre, Professor of Gynaecological Cancer, University of Birmingham

Mr Jo Nieto, Chair of Training Subgroup and Consultant Gynaecological Oncologist, Norfolk and Norwich University Hospitals

National Cancer Registration and Analysis Service (NCRAS)

Dr Charlie Turner, Senior Cancer Data Analyst, National Cancer Registration and Analysis Service (NCRAS)

Dr Craig Knott, Principal Health Data Analyst, Health Data Insight and National Cancer Registration and Analysis Service (NCRAS)

Lizz Paley, Partnerships Analytical Lead, National Cancer Registration and Analysis Service (NCRAS) 

This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS England.

Last edited: 12 April 2023 12:38 pm